Effect of penetration enhancers on isosorbide dinitrate penetration through rat skin from a transdermal therapeutic system

International Journal of Pharmaceutics

Volumn 199, Issue 1, 2000, Pages 1-6

  Gabiga, Halina ^a   Cal, Krzysztof ^a   Janicki, Stanislaw ^a  

^a MEDICAL UNIVERSITY OF GDANSK   (Poland)

Author keywords

Isosorbide dinitrate; Isosorbide mononitrate; Percutaneous absorption; Skin penetration enhancers

Indexed keywords

ACRYLIC CEMENT; DRUG METABOLITE; ISOSORBIDE 2 NITRATE; ISOSORBIDE 5 NITRATE; ISOSORBIDE DINITRATE; KODAKRYL; MACROGOL 400; MYRISTIC ACID ISOPROPYL ESTER; OLEIC ACID; PROPYLENE GLYCOL; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SKIN PENETRATION; SPECTROPHOTOMETRY; TRANSDERMAL DRUG ADMINISTRATION;

ADMINISTRATION, CUTANEOUS; ANIMALS; AREA UNDER CURVE; BIOTRANSFORMATION; EXCIPIENTS; INJECTIONS, INTRAVENOUS; ISOSORBIDE DINITRATE; MALE; MYRISTATES; OLEIC ACID; POLYETHYLENE GLYCOLS; PROPYLENE GLYCOL; RATS; RATS, WISTAR; SKIN ABSORPTION; VASODILATOR AGENTS;

EID: 0034630373     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-5173(99)00363-4     Document Type: Article

References (13)

1. Babko A.K., Pilipenko A.T. Analiza Kolorymetryczna (in Polish). 1955;PWT, Warszawa.
2. Danjo K., Kitamura Y., Miyagawa Y., Otsuka A. Release of isosorbide dinitrate from polymer film dosage forms and absorption of this drug through the oral mucosa of rats. Chem. Pharm. Bull. 42:1994;2126-2130.
3. Down W.H., Chasseaud L.F., Grundy R.K. Biotransformation of isosorbide dinitrate in humans. J. Pharm. Sci. 63:1974;1147-1149.
4. Feldstein M.M., Tohmakhchi V.N., Malkhazov L.B., Vasiliev A.E., Platé N.A. Hydrophilic polymeric matrices for enhanced transdermal drug delivery. Int. J. Pharm. 131:1996;229-242.
5. Goldberg-Cettina M., Liu P., Nightingale J., Kurihara-Bergstrom T. Enhanced transdermal delivery of estradiol in vitro using binary vehicles of isopropyl myristate and short-chain alkanols. Int. J. Pharm. 114:1995;237-245.
6. Gomita Y., Furuno K., Araki Y. Influence of electric foot shock on pharmacokinetics of isosorbide dinitrate orally administered to rats. Japan. J. Pharmacol. 49:1989;297-299.
7. Keller-Stanislawski B., Marschner J.-P., Rietbrock N. Pharmakokinetik von niedrigdosiertem isosorbiddinitrat und metaboliten nach bukkaler und oraler gabe. Arzneim.-Forsch. Drug Res. 42(I):1992;17-20.
8. Kietzmann M., Wenzel B., Löscher W., Lubach D., Müller B.W., Blume H. Absorption of isosorbide dinitrate after administration as spray ointment and microemulsion patch: an in-vitro study using the isolated perfused bovine udder. J. Pharm. Pharmacol. 47:1995;22-25.
9. Laufen H., Leitold M. Bioavailability and metabolism of isosorbide dinitrate from a transdermal spray. Arzneim.-Forsch. Drug Res. 42:1992;931-935.
10. Menke G., Schnellhammer R., Rietbrock N. Konzentrations-zeit-profil von isosorbiddinitrat und seinen metaboliten im plasma nach perkutaner resorption aus einem trasdermalen therapeutischen system. Arzneim.-Forsch. Drug. Res. 37(II):1987;1301-1303.
11. Nozaki Y., Yukimatsu K., Mayumi T. A new transmucosal therapeutic system for the systemic delivery of isosorbide dinitrate: in vitro and in vivo evaluation in beagle dogs. STP Pham. Sci. 6(2):1996;134-141.
12. Nozaki Y., Ohta M., Chien Y.W. Transmucosal controlled systemic delivery of isosorbide dinitrate: in vivo/in virto correlation. J. Control. Release. 43:1997;105-114.
13. Riviere J.E., Brooks J.D., Williams P.L., McGown E., Francoeur M.L. Cutaneous metabolism of isosorbide dinitrate after transdermal administration in isolated perfused porcine skin. Int. J. Pharm. 127:1996;213-217.